Temozolomide in combination with BCNU before and after radiotherapy in patients with inoperable newly diagnosed glioblastoma multiforme (Q33366011)

26 July 2017

Temozolomide in combination with BCNU before and after radiotherapy in patients with inoperable newly diagnosed glioblastoma multiforme (English)

1 reference

Adaptive radiation therapy

26 July 2017

0 references

0 references

1 reference

O Chinot

11

0 references

author name string

M Barrié

1

1 reference

26 July 2017

C Couprie

2

1 reference

26 July 2017

H Dufour

3

1 reference

26 July 2017

D Figarella-Branger

4

1 reference

26 July 2017

X Muracciole

5

1 reference

26 July 2017

K Hoang-Xuan

6

1 reference

26 July 2017

D Braguer

7

1 reference

26 July 2017

P M Martin

8

1 reference

26 July 2017

J C Peragut

9

1 reference

26 July 2017

F Grisoli

10

1 reference

26 July 2017

27 April 2005

1 reference

26 July 2017

1 reference

26 July 2017

16

1 reference

26 July 2017

7

1 reference

26 July 2017

1177-1184

1 reference

Should radiotherapy be standard therapy for brain tumors in the elderly? Cons.

26 July 2017

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDI225

Comparison of postoperative radiotherapy and combined postoperative radiotherapy and chemotherapy in the multidisciplinary management of malignant gliomas. A joint Radiation Therapy Oncology Group and Eastern Cooperative Oncology Group study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDI225

Randomized trial of three chemotherapy regimens and two radiotherapy regimens and two radiotherapy regimens in postoperative treatment of malignant glioma. Brain Tumor Cooperative Group Trial 8001.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDI225

Randomized trial of procarbazine, lomustine, and vincristine in the adjuvant treatment of high-grade astrocytoma: a Medical Research Council trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDI225

Chemotherapy in adult high-grade glioma: a systematic review and meta-analysis of individual patient data from 12 randomised trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDI225

DNA mismatch repair and O6-alkylguanine-DNA alkyltransferase analysis and response to Temodal in newly diagnosed malignant glioma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDI225

Pre-irradiation carboplatin and etoposide and accelerated hyperfractionated radiation therapy in patients with high-grade astrocytomas: a phase II study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDI225

Up-front chemotherapy with fotemustine (F) / cisplatin (CDDP) / etoposide (VP16) regimen in the treatment of 33 non-removable glioblastomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDI225

A phase II study of preradiation chemotherapy followed by external beam radiotherapy for the treatment of patients with newly diagnosed glioblastoma multiforme: an Eastern Cooperative Oncology Group study (E2393).

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDI225

Inactivation of O6-alkylguanine-DNA alkyltransferase in human peripheral blood mononuclear cells by temozolomide.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDI225

Phase 2 study of BCNU and temozolomide for recurrent glioblastoma multiforme: North American Brain Tumor Consortium study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDI225

Phase II study of neoadjuvant 1, 3-bis (2-chloroethyl)-1-nitrosourea and temozolomide for newly diagnosed anaplastic glioma: a North American Brain Tumor Consortium Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDI225

A randomized phase I and pharmacological trial of sequences of 1,3-bis(2-chloroethyl)-1-nitrosourea and temozolomide in patients with advanced solid neoplasms

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDI225

Response criteria for phase II studies of supratentorial malignant glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDI225

Recursive partitioning analysis of prognostic factors in three Radiation Therapy Oncology Group malignant glioma trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDI225

Phase II study of continuous infusion carmustine and cisplatin followed by cranial irradiation in adults with newly diagnosed high-grade astrocytoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDI225

Survival after stereotactic biopsy of malignant gliomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDI225

Radiotherapy and chemotherapy with or without carbogen and nicotinamide in inoperable biopsy-proven glioblastoma multiforme

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDI225

21 January 2018

Identifiers

DOI

10.1093/ANNONC/MDI225

1 reference

26 July 2017

1 reference